Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease

被引：0
|
作者：
Stefan Schreiber
Axel Dignass
Laurent Peyrin-Biroulet
Greg Hather
Dirk Demuth
Mahmoud Mosli
Rebecca Curtis
Javaria Mona Khalid
Edward Vincent Loftus
机构：
[1] Christian-Albrechts-University,Department of Internal Medicine I and Institute of Clinical Molecular Biology, University
[2] Goethe University,Hospital Schleswig
[3] Lorraine University,Holstein
[4] Takeda Oncology,Department of Medicine 1, Agaplesion Markus Hospital
[5] Takeda Global Research and Development,Inserm U954 and Gastroenterology Department, Nancy University Hospital
[6] Takeda International-UK Branch,Global Medical Affairs
[7] King Abdulaziz University,Department of Medicine
[8] Mayo Clinic College of Medicine,Department of Gastroenterology and Hepatology
来源：
Journal of Gastroenterology | 2018年 / 53卷
关键词：
Vedolizumab; Inflammatory bowel disease; Ulcerative colitis; Crohn’s disease; Real-world effectiveness;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1048 / 1064
页数：16
相关论文
共 50 条
  • [21] Real world effectiveness of vedolizumab over one year in inflammatory bowel disease: a meta-analysis
    Schreiber, S.
    Dignass, A.
    Peyrin-Biroulet, L.
    Hather, G.
    Demuth, D.
    Khalid, J. M.
    Loftus, E. V.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S315 - S315
  • [22] Effectiveness and Safety of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Sailish Honap
    Susanna Meade
    Hajir Ibraheim
    Peter M. Irving
    Michael P. Jones
    Mark A. Samaan
    Digestive Diseases and Sciences, 2022, 67 : 1018 - 1035
  • [23] Effectiveness and Safety of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Honap, Sailish
    Meade, Susanna
    Ibraheim, Hajir
    Irving, Peter M.
    Jones, Michael P.
    Samaan, Mark A.
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (03) : 1018 - 1035
  • [24] Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis
    Peyrin-Biroulet, Laurent
    Arkkila, Perttu
    Armuzzi, Alessandro
    Danese, Silvio
    Guardiola, Jordi
    Jahnsen, Jorgen
    Lees, Charles
    Louis, Edouard
    Lukas, Milan
    Reinisch, Walter
    Roblin, Xavier
    Jang, Minyoung
    Byun, Han Geul
    Kim, Dong-Hyeon
    Lee, Sung Jeong
    Atreya, Raja
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [25] Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis
    Laurent Peyrin-Biroulet
    Perttu Arkkila
    Alessandro Armuzzi
    Silvio Danese
    Jordi Guardiola
    Jørgen Jahnsen
    Charles Lees
    Edouard Louis
    Milan Lukáš
    Walter Reinisch
    Xavier Roblin
    Minyoung Jang
    Han Geul Byun
    Dong-Hyeon Kim
    Sung Jeong Lee
    Raja Atreya
    BMC Gastroenterology, 22
  • [26] The efficacy, safety, and persistence of vedolizumab versus adalimumab in patients with inflammatory bowel disease: a systematic review and meta-analysis
    Chen, Zhixin
    Li, Huo
    Li, Zhongzhuan
    Ouyang, Rong
    Huang, Shijiang
    Qin, Shufen
    Qin, Jing
    Huang, Jiean
    INFLAMMOPHARMACOLOGY, 2025, : 1761 - 1773
  • [27] Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis
    Ronnstad, Amalie Thorsti Moller
    Bunick, Christopher G.
    Chovatiya, Raj
    Kamata, Masahiro
    Nielsen, Mia-Louise
    Isufi, Daniel
    Thomsen, Simon F.
    Vestergaard, Christian
    Wollenberg, Andreas
    Egeberg, Alexander
    Thyssen, Jacob P.
    Loft, Nikolai
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2025,
  • [28] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hsu, Diane
    Lee, Justin
    Kotzen, Alison Borrman
    Bensen, Rachel
    Goyal, Alka
    GASTROENTEROLOGY, 2024, 166 (05) : S1210 - S1211
  • [29] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hsu, Diane
    Lee, Justin
    Kotzen, Alison
    Bensen, Rachel
    Goyal, Alka
    GASTROENTEROLOGY, 2024, 166 (03) : S101 - S102
  • [30] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hsu, Diane
    Lee, Justin
    Kotzen, Alison
    Bensen, Rachel
    Goyal, Alka
    INFLAMMATORY BOWEL DISEASES, 2024, 30 : S73 - S74
12345